CLEC9A and neoplasm: The unique ability of migratory cDC1s to cross-present tumor antigens to CD8+ T cells might be related to reduced antigen degradation in phagocytic compartments [40], as well as the ability of cDC1s to use DNGR-1 to shuttle material from dead cells into specialized endocytic compartments [41].